Gu Lin, Xin Gaojie, Qu Yue, Wang Kai, Jiang Ke, Xing Shijie, Huang Ai
Department of Thoracic Surgery, Huazhong University of Science and Technology Union Shenzhen Hospital, Guangdong, China.
Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Surg. 2023 May 3;10:1088642. doi: 10.3389/fsurg.2023.1088642. eCollection 2023.
Compound lymphoma is an uncommon type of lymphoid malignancy, and those consisting of concurrent B- and T-cell tumors are relatively rare.
A 41-year-old man was presented with a 1-month history of progressively worsening cough, chest tightness, and dyspnea after exercise, which could be relieved following rest. Contrast-enhanced computed tomography scan demonstrated a 7.4 × 4.9 cm heterogeneous mass in the anterior mediastinum, where a large area of cystic liquid existed, and multiple enlarged lymph nodes in the mediastinum. Since the biopsy failed to yield an exact diagnosis and there was no sign of metastasis, the tumor was surgically resectioned. Surgical findings included obscure boundaries and consistent tumor stiffness with pericardial and pleural invasion. Further pathological examination combined with immunophenotype and gene rearrangement test found the mass composite of angioimmunoblastic T-cell lymphoma (AITL) and B-cell lymphoma. The patient recovered well after R0 resection and received chemotherapy with four cycles of CHOP combined with chidamide 2 weeks after surgery. The patient has had a complete response for over 60 months.
In conclusion, we reported a composite lymphoma of AITL combined with B-cell lymphomas. Our experience provides the first successful attempt to treat this rare disease with combined surgery and chemotherapy.
复合淋巴瘤是一种罕见的淋巴系统恶性肿瘤,由同时存在的B细胞和T细胞肿瘤组成的病例相对少见。
一名41岁男性,有1个月渐进性加重的咳嗽、胸闷病史,运动后出现呼吸困难,休息后可缓解。增强计算机断层扫描显示前纵隔有一个7.4×4.9 cm的不均匀肿块,其中存在大片囊性液体,纵隔内有多个肿大淋巴结。由于活检未能明确诊断且无转移迹象,遂对肿瘤进行手术切除。手术所见包括边界不清,肿瘤质地与心包和胸膜侵犯一致。进一步的病理检查结合免疫表型和基因重排检测发现肿块为血管免疫母细胞性T细胞淋巴瘤(AITL)和B细胞淋巴瘤的复合体。患者R0切除术后恢复良好,术后2周接受了4周期CHOP联合西达本胺化疗。患者已完全缓解超过60个月。
总之,我们报告了一例AITL合并B细胞淋巴瘤的复合淋巴瘤。我们的经验为联合手术和化疗治疗这种罕见疾病提供了首次成功尝试。